Gang Cao | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Gang Cao | Behavioral Neuroscience | Best Researcher Award

Anhui University of Finance and Economics | China

Gang Cao (Ph.D.) is a Lecturer at the International Business School, Anhui University of Finance and Economics, with academic training in Business Administration and Management Science and Engineering from Shanghai University and Anhui University of Finance and Economics. His research focuses on AI capabilities, entrepreneurship, and innovation, and he has published in leading international journals such as the Journal of Business Research, Management and Organization Review, R&D Management, Plos One, and the International Journal of Conflict Management, as well as in top Chinese journals including Journal of Management Sciences in China and Journal of Economic Management. He has authored and co-authored multiple high-impact studies addressing themes such as entrepreneurial well-being, entrepreneurial failure and reentry, bricolage and disruptive innovation, digital identity change, impression management, and the integration of artificial intelligence with entrepreneurship and business model innovation. His work combines quantitative, qualitative, and computational methodologies, offering both theoretical contributions and practical insights into entrepreneurial behavior and firm evolution. Gang Cao has achieved an h-index of 5, with 11 documents and 102 citations, reflecting his growing academic impact and recognition in the fields of entrepreneurship, innovation management, and digital transformation. Through his interdisciplinary and collaborative research, he continues to advance understanding of the complex dynamics driving entrepreneurial success and organizational performance.

Profiles: Google Scholar

Featured Publications

“Exploring the relationship between entrepreneurial failure and conflict between work and family from the conservation of resources perspective.”

“Entrepreneurial Bricolage and Disruptive Innovation: The Joint Effect of Learning From Failure and Institutional voids.”

“Striking the balance: Configurations of causation and effectuation principles for SME performance.”

Wilfred Angie Abia | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Wilfred Angie Abia | Developmental Neuroscience | Best Researcher Award

Dr. Wilfred Angie Abia |  University of Yaounde 1 | Cameroon

Wilfred Angie Abia is an accomplished biochemist and food safety toxicologist whose career bridges Africa and Europe through impactful teaching, research, and international collaborations. His academic foundation in medical biochemistry, nutrition, and toxicology has evolved into a distinguished career specializing in food contaminants, mycotoxin biomonitoring, fraud detection, and risk assessment. He has held influential postdoctoral and leadership positions in projects addressing agri-food safety and consumer health protection. His contributions span mycotoxicology, food fraud prevention, One Health research, and climate-related food safety challenges. Beyond research, he plays an important role as a senior lecturer and mentor, advancing both academic excellence and professional training in food safety.

Profile

Google Scholar
Orcid
Scopus

Early Academic Pursuits

Wilfred Angie Abia began his academic journey with a strong foundation in biochemistry, focusing on medical laboratory technology, nutritional sciences, and food safety. His doctoral studies at the University of Yaoundé I provided him with advanced expertise in food contaminants, safety, and biomonitoring of multimycotoxin exposures. His early academic years were marked by interdisciplinary training that connected biochemistry, nutrition, toxicology, and public health, setting the stage for his specialized career in agri-food safety and toxicology.

Professional Endeavors

His professional career spans teaching, research, and project management across multiple institutions and international collaborations. He has held postdoctoral fellowships and senior research positions in Africa, Europe, and the United Kingdom, where he advanced projects on food safety, toxicology, and fraud detection. His work at Queen’s University Belfast included leadership roles in large-scale European initiatives, where he served as both a researcher and project manager. As a Senior Lecturer of Biochemistry and Food Safety/Toxicology at the University of Yaoundé I, he combines teaching, mentorship, and research with program coordination responsibilities, shaping the next generation of food safety professionals.

Contributions and Research Focus

Abia’s research focuses on food contaminants, safety, and human health with a special emphasis on mycotoxicology. He has pioneered studies in exposure assessment, biomarker development, and human biomonitoring, particularly in vulnerable populations. His work extends to food integrity, authenticity, fraud detection, and traceability, ensuring consumer health protection. He has contributed significantly to toxicological risk assessments of chemicals in food, drugs, and the environment, while also addressing broader themes such as climate change, food security, and the One Health approach. His unique contributions include research into the neurotoxicology of mycotoxins, highlighting the intersection of food safety and neuroscience.

Accolades and Recognition

Throughout his career, Abia has been recognized through prestigious international research fellowships and visiting scholar positions in leading research centers across Europe and Africa. His involvement in high-impact projects such as MycoMarker and FoodSafer underscores his leadership in global food safety initiatives. His achievements are further strengthened by professional certifications, including specialized training in food fraud prevention, which demonstrate his commitment to continuous professional growth and excellence in his field.

Impact and Influence

His work has had a profound impact on advancing food safety research, shaping policies, and protecting public health. By bridging biochemistry with toxicology, agri-food safety, and environmental sciences, he has influenced how food contaminants and fraud are detected and managed. His role as a lecturer and mentor ensures that his expertise is transmitted to students and young researchers who will continue to advance the field. His contributions also extend to policy and science diplomacy, where he actively promotes interdisciplinary collaboration for sustainable solutions in food and health security.

Legacy and Future Contributions

Abia’s legacy lies in his dedication to safeguarding food systems, advancing toxicological research, and promoting interdisciplinary approaches that connect human, animal, and environmental health. His work in mycotoxin biomonitoring and neurotoxicology offers critical insights into the hidden health risks of food contamination. Looking ahead, his future contributions are likely to expand in areas of food fraud prevention, climate-smart agriculture, and One Health frameworks, ensuring resilient food systems for global populations. His combination of research excellence, teaching, and science diplomacy positions him as a thought leader in shaping the future of food safety and toxicology.

Publications

  • Title: Determination of multi-mycotoxin occurrence in cereals, nuts and their products in Cameroon by liquid chromatography tandem mass spectrometry (LC-MS/MS)
    Authors: WA Abia, B Warth, M Sulyok, R Krska, AN Tchana, PB Njobeh, MF Dutton, …
    Year: 2013

  • Title: Mycotoxin exposure in rural residents in northern Nigeria: A pilot study using multi-urinary biomarkers
    Authors: CN Ezekiel, B Warth, IM Ogara, WA Abia, VC Ezekiel, J Atehnkeng, …
    Year: 2014

  • Title: Development and validation of a rapid multi‐biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins
    Authors: B Warth, M Sulyok, P Fruhmann, H Mikula, F Berthiller, R Schuhmacher, …
    Year: 2012

  • Title: Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach
    Authors: WA Abia, B Warth, M Sulyok, R Krska, A Tchana, PB Njobeh, PC Turner, …
    Year: 2013

  • Title: Ultra-sensitive, stable isotope assisted quantification of multiple urinary mycotoxin exposure biomarkers
    Authors: B Šarkanj, CN Ezekiel, PC Turner, WA Abia, M Rychlik, R Krska, M Sulyok, …
    Year: 2018

  • Title: Low doses of mycotoxin mixtures below EU regulatory limits can negatively affect the performance of broiler chickens: A longitudinal study
    Authors: O Kolawole, A Graham, C Donaldson, B Owens, WA Abia, J Meneely, …
    Year: 2020

  • Title: Urinary analysis reveals high deoxynivalenol exposure in pregnant women from Croatia
    Authors: B Šarkanj, B Warth, S Uhlig, WA Abia, M Sulyok, T Klapec, R Krska, …
    Year: 2013

Conclusion

Wilfred Angie Abia’s work exemplifies a rare integration of scientific expertise, international leadership, and educational impact. His contributions to food safety, toxicology, and agri-food research not only safeguard public health but also strengthen global food systems. With his continued focus on innovation, interdisciplinary approaches, and capacity building, he stands as a key figure in shaping the future of food safety science and policy worldwide.

Edythe London | Behavioral Neuroscience | Distinguished Scientist Award

Published on by Neuroscientists

Dr. Edythe London | Behavioral Neuroscience | Distinguished Scientist Award

Dr. Edythe London | University of California Los Angeles | United States

Dr. Edythe D. London is an internationally recognized neuroscientist and pharmacologist whose career has been dedicated to understanding the brain mechanisms underlying addiction. With a strong academic foundation in zoology, chemistry, pharmacology, and neurobiology, she advanced into leadership roles at the National Institutes of Health before becoming a distinguished professor at UCLA. Her pioneering work in applying brain imaging technologies to addiction research has revealed how drugs alter brain circuits and influence behavior, providing essential knowledge for developing treatments. Beyond research, she has served in influential roles on national policy panels, scientific advisory boards, and university committees, while also mentoring future leaders in the field. Her expertise has been sought after by both academic and pharmaceutical communities, underscoring the breadth of her impact.

Profile

Scopus

Early Academic Pursuits

Edythe D. London embarked on her academic journey with a deep interest in the biological sciences, pursuing undergraduate studies in zoology with a complementary focus on chemistry. She advanced her training in biological sciences through graduate studies before earning her doctorate in pharmacology with a supporting program in neurobiology. These formative years built a strong foundation for her future career in neuropsychopharmacology, a field she further explored during her postdoctoral fellowship at the Johns Hopkins School of Medicine. Her early academic development was characterized by an integration of biology, chemistry, and neuroscience, which set the stage for her pioneering work in addiction research.

Professional Endeavors

Her professional career began with positions at the National Institute on Aging and later at the National Institute on Drug Abuse, where she advanced from pharmacologist to leadership roles including chief of laboratories and director of brain imaging programs. These responsibilities allowed her to combine pharmacology with cutting-edge neuroimaging approaches. She later transitioned to academia, holding professorial roles at leading institutions including the University of Maryland, Johns Hopkins University, and UCLA. At UCLA, she became the Thomas P. and Katherine K. Pike Professor in Addiction Studies and Distinguished Professor-in-Residence, while also holding an adjunct appointment at the Icahn School of Medicine at Mount Sinai. These roles positioned her at the intersection of research, teaching, and clinical innovation.

Contributions and Research Focus

Dr. London’s work has consistently focused on the neurobiology of addiction and the application of imaging technologies to understand brain function. She pioneered the use of positron emission tomography and functional magnetic resonance imaging to investigate how drugs of abuse alter brain circuits involved in reward, decision-making, and impulse control. Her studies have provided crucial insights into the mechanisms of nicotine, cocaine, methamphetamine, and other substances, while also addressing behavioral and cognitive dimensions of dependence. Beyond drug effects, her research has explored vulnerability factors and treatment responses, shaping both scientific understanding and therapeutic strategies for addiction.

Leadership and Service

In addition to her research, Dr. London has provided leadership in numerous governmental, institutional, and advisory committees. She chaired panels for the Office of National Drug Control Policy, served on central tenure committees for the National Institutes of Health, and contributed to advisory boards at Yale, UC San Diego, Duke, and other leading centers. Her service has extended across animal care, ethics, promotions, and research development programs, reflecting her commitment to strengthening scientific integrity and mentoring new generations of investigators.

Accolades and Recognition

Throughout her career, Dr. London has been recognized as a leading authority in addiction studies and neuropharmacology. Her appointment to named professorships at UCLA underscores the high esteem in which she is held by the academic and medical communities. Invitations to serve on scientific advisory boards, external committees, and national policy panels further highlight the respect accorded to her expertise. She has also been a trusted consultant to major pharmaceutical companies, advising on drug development and the translation of neuroscience discoveries into therapeutic innovation.

Impact and Influence

Dr. London’s influence extends beyond her direct research contributions. Her pioneering integration of brain imaging into addiction science has inspired a generation of researchers to adopt multidisciplinary approaches. By linking pharmacology, neurobiology, and behavioral science, she helped establish addiction research as a rigorous scientific discipline with broad societal relevance. Her mentorship of trainees, leadership in institutional initiatives, and consultation for industry have amplified her impact, ensuring that her work resonates across research, clinical practice, and public health policy.

Legacy and Future Contributions

The legacy of Dr. Edythe D. London lies in her trailblazing role in addiction neuroscience and her enduring influence on the field of brain imaging research. Her contributions continue to guide the development of gender-sensitive treatments, tobacco dependence programs, and innovative strategies for addressing substance use disorders. As a distinguished scholar and mentor, she has set standards for excellence that will shape future research trajectories. Her ongoing involvement in advisory roles and collaborative projects ensures that she remains at the forefront of advancing knowledge in neuroscience and addiction medicine, leaving a lasting imprint on science, medicine, and society.

Publications

  • Comparing neuromodulation targets to reduce cigarette craving and withdrawal: a randomized clinical trial — [Authors not listed in preview] — 2025

  • Brain mGlu5 Is Linked to Cognition and Cigarette Smoking but Does Not Differ From Control in Early Abstinence From Chronic Methamphetamine Use — [Authors not listed in preview] — 2024

  • Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review — [Authors not listed in preview] — 2024

  • Structural indices of brain aging in methamphetamine use disorder — [Authors not listed in preview] — 2024

  • Convergent Validity of Experimental Cognitive Tests in a Large Community Sample — [Authors not listed in preview] — 2024

  • Mindfulness and clinical correlates in methamphetamine use disorder — [Authors not listed in preview] — 2023

  • Value-based decision-making predicts alcohol use and related problems in young men — [Authors not listed in preview] — 2023

  • Smoking, tobacco dependence, and neurometabolites in the dorsal anterior cingulate cortex — [Authors not listed in preview] — 2023

  • Polygenic contributions to performance on the Balloon Analogue Risk Task — [Authors not listed in preview] — 2023

  • Negative affect and craving during abstinence from smoking are both linked to default mode network connectivity — [Authors not listed in preview] — 2023

Conclusion

Dr. London’s career reflects a rare combination of scientific innovation, leadership, and service. By bridging pharmacology, neuroimaging, and behavioral science, she transformed the understanding of addiction and shaped therapeutic strategies that continue to influence public health. Her legacy is defined not only by her pioneering discoveries but also by her commitment to advancing research integrity, mentoring emerging scholars, and guiding national and international efforts in addiction medicine. She stands as a highly influential figure whose contributions will continue to inform neuroscience and addiction research for years to come.

Saeid Abbasi Maleki | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Saeid Abbasi Maleki | Behavioral Neuroscience | Best Researcher Award

Assoc. Prof. Dr.  Saeid Abbasi  Maleki | Kermanshah University of Medical Sciences | Iran

Dr. Saeid Abbasi Maleki is a distinguished academic whose career bridges veterinary medicine, pharmacology, and behavioral neuroscience. Beginning with a veterinary degree and early research on poultry health, he advanced into pharmacological studies with a doctoral focus on the role of amantadine and SSRIs in morphine reinforcement models. His academic journey has been marked by significant teaching roles, leadership in research councils, and departmental headship, reflecting his recognition as a respected scholar. His research contributions highlight an interdisciplinary approach, connecting animal health sciences with human medical insights, while his administrative service underscores his commitment to advancing academic institutions.

Profile

Google Scholar

Early Academic Pursuits

Saeid Abbasi Maleki began his academic journey with a strong foundation in veterinary medicine, earning his degree in the field from Urmia Branch of the Islamic Azad University. His early studies reflected a deep interest in animal health and management, which was exemplified by his doctoral thesis on the health assessment and management of broilers in Maragheh city. This work revealed his early inclination toward applying medical knowledge for both practical and scientific advancement, laying the groundwork for his later research endeavors.

Professional Endeavors

Following his graduation, he pursued advanced studies in pharmacology at the Science and Research Branch in Tehran, where he earned his doctorate. His research during this time concentrated on the effects of pharmacological agents such as amantadine and selective serotonin reuptake inhibitors in models of morphine reinforcement, a field of study that bridged pharmacology and neuroscience. His career subsequently flourished in academia, serving as a university professor and holding administrative and leadership positions in research councils and departmental management.

Contributions and Research Focus

Dr. Maleki’s contributions extend across veterinary medicine, pharmacology, and behavioral neuroscience. His investigations into drug interactions and reinforcement mechanisms demonstrated an interdisciplinary approach, combining veterinary sciences with human medical research. This focus reflects his ability to translate findings across species and contribute to broader understandings of drug action, dependence, and therapeutic intervention. His research trajectory continues to explore the intersection of pharmacological science and health management.

Accolades and Recognition

Over the course of his academic service, he has held significant roles that highlight his recognition within the scientific community. Serving as a professor in leading institutions and as a member of research councils reflects the esteem with which his colleagues regard his expertise. His leadership as head of a department further underscores the respect he has earned for his commitment to advancing education and research.

Impact and Influence

Through both teaching and research, Dr. Maleki has influenced generations of students and professionals in the fields of veterinary and medical sciences. His dual focus on practical veterinary applications and experimental pharmacological studies demonstrates a capacity to shape interdisciplinary approaches. By bridging different domains of health sciences, he has contributed to developing new perspectives on both animal and human well-being.

Legacy in Academic Development

His legacy lies not only in his published research and scientific contributions but also in the academic culture he has helped foster. Through his long-standing commitment to teaching and departmental leadership, he has advanced the mission of the institutions he has served. By guiding research directions and supporting collaborative initiatives, he has played a key role in shaping the academic and scientific environment for future scholars.

Future Contributions

Looking ahead, Dr. Maleki’s ongoing work at Kermanshah University of Medical Science reflects his continued dedication to research and teaching. His expertise positions him to make further contributions to the evolving field of pharmacology and its applications in health sciences. His interdisciplinary focus promises to deepen insights into drug interactions, behavior, and health, ensuring his influence will remain significant in the years to come.

Publications

  • Design, preparation and characterization of urea-functionalized Fe3O4/SiO2 magnetic nanocatalyst and application for the one-pot multicomponent synthesis of substituted … – A Maleki, Z Alrezvani, S Maleki – 2015

  • Evaluation of antidepressant-like effects of aqueous and ethanolic extracts of Pimpinella anisum fruit in mice – Z Shahamat, S Abbasi-Maleki, SM Motamed – 2016

  • The antidepressant-like effects of Origanum majorana essential oil on mice through monoaminergic modulation using the forced swimming test – S Abbasi-Maleki, Z Kadkhoda, R Taghizad-Farid – 2020

  • Data mining and medical world: breast cancers’ diagnosis, treatment, prognosis and challenges – RJ Oskouei, NM Kor, SA Maleki – 2017

  • Antibacterial activity of the fruits of Iranian Torilis leptophylla against some clinical pathogens – S Maleki, SM Seyyednejad, NM Damabi, H Motamedi – 2008

  • A preliminary study on the antibacterial activity of Quercus brantii against bacterial pathogens, particularly enteric pathogens – A Safary, H Motamedi, S Maleki, SM Seyyednejad – 2009

  • Antibacterial activity of Prunus mahaleb and Parsley (Petroselinum crispum) against some pathogen – SM Seyyednejad, S Maleki, NM Damabi, H Motamedi – 2008

  • Folate-conjugated thermal-and pH-responsive magnetic hydrogel as a drug delivery nano-system for “smart” chemo/hyperthermia therapy of solid tumors – H Derakhshankhah, B Haghshenas, M Eskandani, R Jahanban-Esfahlan, … – 2022

  • Ziziphus spina-christi, a native plant from Khuzestan, Iran, as a potential source for discovery new antimicrobial agents – H Motamedi, A Safary, S Maleki, SM Seyyednejad – 2009

  • Antibacterial effects of Solanum tuberosum peel ethanol extract in vitro – R Amanpour, S Abbasi-Maleki, M Neyriz-Naghadehi, M Asadi-Samani – 2015

  • Thermal performance analysis of mechanical draft cooling tower filled with rotational splash type packing by using nanofluids – M Amini, M Zareh, S Maleki – 2020

Conclusion

Through his dual commitment to research and teaching, Dr. Maleki has made a lasting impact on the scientific and academic community. His work has shaped understanding of pharmacological mechanisms while nurturing future professionals in health sciences. With a strong foundation of achievement and recognition, his legacy continues to influence veterinary and pharmacological research, while his current and future contributions promise to expand knowledge in drug interactions and health management.

Gulcin Gacar | Neurodegenerative Disease | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Gulcin Gacar | Neurodegenerative Disease | Best Researcher Award

Prof. Dr. Gulcin Gacar | Kocaeli University | Turkey

Associate Professor Dr. Gulcin Gacar of Kocaeli University is a distinguished researcher and educator in the fields of stem cell biology, regenerative medicine, and clinical microbiology. With over 200 scientific publications, including 54 in Web of Science and 37 in Scopus, she has garnered more than 900 citations and achieved an h-index of 17. Her groundbreaking research focuses on mesenchymal stem cells and exosomes, particularly their applications in neurodegenerative diseases like Alzheimer’s. She leads nationally funded projects and serves as a mentor to graduate students, contributing significantly to Turkey’s scientific advancement in cellular and molecular therapy.

Academic Profile

Google Scholar
Orcid

Early Academic Pursuits

From the outset of her academic journey, Dr. Gülçin Gacar exhibited a strong dedication to medical sciences, particularly clinical microbiology and regenerative medicine. Her foundational studies laid the groundwork for her specialization in stem cell biology and advanced biomedical techniques. As she advanced through the academic ranks, her commitment to translational research became evident, inspiring a deep dive into the dynamic world of mesenchymal stem cells and cellular therapies.

Professional Endeavors

Currently serving as an Associate Professor at Kocaeli University, Dr. Gacar is affiliated with the Center for Stem Cell and Gene Therapies under the Institute of Health Sciences. She plays a critical role in bridging theoretical knowledge with clinical application. Her professional journey is characterized by a robust combination of teaching, research, and leadership, where she supervises graduate-level research and oversees important institutional initiatives in stem cell-based innovation.

Contributions and Research Focus

Dr. Gacar’s research primarily revolves around mesenchymal stem cells, exosomes (extracellular vesicles), and advanced applications of stem cell biology. One of her key projects involves investigating the therapeutic potential of exosomes derived from adipose tissue-origin mesenchymal stem cells on Alzheimer’s disease models using human neuroblastoma SHSY5Y cells. This cutting-edge study, supported by national scientific funding, illustrates her focus on neurological disorders and cellular therapies. With over 200 academic publications, including 54 indexed in Web of Science and 37 in Scopus, her work has become a cornerstone in regenerative medicine and neurocellular research.

Accolades and Recognition

Dr. Gacar’s exceptional scholarship is reflected in her impressive citation record—garnering over 900 citations with an h-index of 16 on Web of Science and 17 on Scopus. These metrics not only underscore the academic relevance of her research but also highlight her influence in the global scientific community. Her contributions have positioned her as a key opinion leader and trusted consultant in TÜBİTAK-funded national projects, further validating her expertise and dedication to scientific excellence.

Impact and Influence

Beyond publications and projects, Dr. Gacar is actively involved in mentoring the next generation of scientists. She has supervised numerous graduate theses, fostering a research culture grounded in innovation, rigor, and ethical science. Her influence extends into policy-making and practical clinical research, making her a vital figure in the implementation of stem cell technologies in both experimental and therapeutic contexts.

Legacy and Future Contributions

Dr. Gacar continues to expand the frontiers of stem cell research and regenerative neuroscience. Her ongoing efforts in developing novel diagnostic and therapeutic modalities through cellular and molecular engineering are poised to transform clinical approaches to degenerative diseases. With each project and publication, she reinforces her commitment to scientific discovery and paves the way for future breakthroughs in biotechnology and personalized medicine.

Neuroscience and Regenerative Innovation

At the intersection of neuroscience and regenerative biology, Dr. Gacar’s work exemplifies the possibilities of interdisciplinary research. Her current focus on exosome-based therapies in neurodegenerative conditions represents a bold step into the future of non-invasive, cell-free therapeutics. As the landscape of neuroscience evolves, her pioneering work will undoubtedly contribute to novel clinical strategies and global scientific advancement.

Publication

Isolation and in vitro characterisation of dental pulp stem cells from natal teeth
E Karaöz, BN Doğan, A Aksoy, G Gacar, S Akyüz, S Ayhan, ZS Genç
2010

Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers
E Karaoz, A Aksoy, S Ayhan, AE Sarıboyacı, F Kaymaz, M Kasap
2009

Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum
K Schallmoser, E Rohde, A Reinisch, C Bartmann, D Thaler, C Drexler, …
2008

High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple …
H Vahaboglu, F Budak, M Kasap, G Gacar, S Torol, A Karadenizli, …
2006

Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems
PC Demircan, AE Sariboyaci, ZS Unal, G Gacar, C Subasi, E Karaoz
2011

Protective effects of resveratrol on aging-induced cognitive impairment in rats
SS Gocmez, N Gacar, T Utkan, G Gacar, PJ Scarpace, N Tumer
2016

The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets
AT Özdemir, RBÖ Özdemir, C Kırmaz, AE Sarıboyacı, ZSÜ Halbutoğlları, …
2016

PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.
F Kolayli, G Gacar, A Karadenizli, A Sanic, H Vahaboglu, Study Group
2005

Phenotypic and proteomic characteristics of human dental pulp derived mesenchymal stem cells from a natal, an exfoliated deciduous, and an impacted third molar tooth
G Akpinar, M Kasap, A Aksoy, G Duruksu, G Gacar, E Karaoz
2014

The role of PIN1 on odontogenic and adipogenic differentiation in human dental pulp stem cells
YM Lee, SY Shin, SS Jue, IK Kwon, EH Cho, ES Cho, SH Park, EC Kim
2014

Conclusion 

Considering her scholarly output, impactful research on stem cell-based therapies, leadership in national research initiatives, and dedication to mentoring, Dr. Gulcin Gacar is highly deserving of the Best Researcher Award. Her innovative work in exosome-based treatment strategies for neurodegenerative diseases positions her as a leader in translational medical science. With continued emphasis on global engagement and high-impact dissemination, her research will not only advance scientific frontiers but also contribute meaningfully to patient care and public health. Thus, she stands as an exemplary model of academic excellence, innovation, and social relevance in biomedical sciences.

Jørgen Slots | Clinical Neuroscience |

Published on by Neuroscientists

Prof. Dr. Jørgen Slots | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jørgen Slots, University of Southern California,  United States.

Dr. Jørgen Slots is an internationally recognized scholar in periodontology and oral microbiology, with a rich academic and professional background rooted in Denmark, the United States, and Sweden. After completing multiple advanced degrees—including a D.D.S., Ph.D., D.M.D., and M.B.A.—he held tenured and leadership roles at esteemed institutions such as the Royal Dental College, SUNYAB, and the University of Göteborg. His research focused on microbial causes of periodontal disease, bridging the gap between laboratory science and clinical treatment. Throughout his career, he has been a pioneer in integrating microbiology into dental education and has significantly influenced both teaching and clinical standards globally. His work continues to inform practices in oral health and inspire the next generation of researchers and clinicians.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born in 1944 in Vejle, Denmark, Dr. Jørgen Slots embarked on a lifelong journey in dentistry and biomedical science that began at the prestigious Royal Dental College in Copenhagen. He earned his D.D.S. in 1969 and continued to delve deeper into academic excellence with an M.S. (Lic. Odont.) in 1974. His passion for periodontology led him to complete postgraduate education in this specialty by 1976, setting the stage for a research-intensive career. Not stopping there, he pursued advanced studies in microbiology at the Forsyth Dental Center in Boston, Massachusetts, where he earned a Certificate in Microbiology in 1977. By 1979, he had completed his doctoral thesis (Dr. Odont./Ph.D.), a reflection of his rigorous scientific training and commitment to academic inquiry.

🧪 Professional Endeavors in Dental Science

Dr. Slots’ career spans both private practice and academia, beginning with clinical work in Copenhagen from 1969 to 1976. However, his true calling was in academia and research, where he quickly rose through the ranks at the Royal Dental College, becoming a tenured associate professor in the Department of Periodontology and Bacteriology. His academic influence extended internationally as he moved to the United States, joining the State University of New York at Buffalo (SUNYAB) as a visiting associate professor in 1977. His multifaceted roles there included teaching, research, and graduate mentorship. In 1982, his expertise was recognized with a professorial and chair appointment at the University of Göteborg in Sweden, where he led the Department of Oral Microbiology until 1986.

🔬 Contributions and Research Focus

Dr. Slots’ core research has focused on periodontal microbiology, particularly the microbial etiology of periodontal diseases and the role of anaerobic bacteria in oral infections. His extensive background in both clinical periodontology and microbiology enabled him to bridge these disciplines, pioneering investigations into microbial pathogenesis, host responses, and antimicrobial therapy. His work at the intersection of dentistry and microbiology has contributed significantly to the understanding of how bacterial biofilms influence periodontal health and disease progression. Through his positions in leading institutions, he has mentored countless students and young researchers in translational oral biology.

🏅 Accolades and Recognition

Throughout his distinguished career, Dr. Slots has earned numerous accolades that acknowledge both his scholarly achievements and teaching excellence. His academic journey includes obtaining a D.M.D. from the University of Pennsylvania in 1986, further consolidating his clinical credentials. In 1989, he expanded his skillset by earning an M.B.A. from the Wharton School, indicating his interest in healthcare administration and leadership. Such accomplishments reflect a rare blend of scientific acumen, clinical expertise, and administrative insight that is seldom seen in one individual. His tenured appointments and leadership roles speak volumes about the respect he commands in his field.

🌍 Impact and Global Influence

Dr. Slots’ contributions have had global implications, influencing not only North American dental education but also shaping European periodontal research. His tenure at institutions in Denmark, Sweden, and the United States illustrates his international standing and thought leadership. By combining laboratory science with clinical application, he has contributed to international standards in oral hygiene practices, periodontal disease diagnostics, and treatment protocols. His collaborative work across continents has helped create a robust, evidence-based approach to periodontal care that is taught and practiced worldwide.

📚 Legacy in Dental Education and Microbiology

As a graduate faculty member and department chair, Dr. Slots played a vital role in curriculum development, graduate training, and interdisciplinary integration of oral microbiology into mainstream dental education. He has influenced a generation of oral biologists and periodontists who continue to build upon his foundational work. His teaching style, grounded in research and clinical relevance, made him a beloved educator and mentor. The ripple effects of his academic stewardship can still be seen in the progressive research and pedagogical models employed at the University of Southern California and other leading dental institutions.

🔭 Future Vision and Continuing Relevance

Though his primary academic career has matured, the legacy of Dr. Slots remains very much alive in ongoing research studies, collaborative clinical trials, and academic dialogues. His integration of clinical practice with microbiological research stands as a model for future dental scientists aiming to address emerging challenges in oral-systemic health. With a unique blend of intellectual rigor and compassionate mentorship, Dr. Slots has laid a foundation that will support future breakthroughs in both academic and applied dental sciences. His life’s work continues to inspire innovation and scientific inquiry in oral health worldwide.

Publication

Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions
A Ashimoto, C Chen, I Bakker, J Slots – 1996

Subgingival microflora and periodontal disease
J Slots – 1979

Periodontitis: facts, fallacies and the future
J Slots – 2017

Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival
J Slots, RJ Genco – 1984

Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases
J Slots, MA Listgarten – 1988

Selective medium for isolation of Actinobacillus actinomycetemcomitans
J Slots – 1982

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: a Cross-Sectional Microbiological Investigation
J Slots, HS Reynolds, RJ Genco – 1980

Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases
ILC Chapple, R Genco, Working Group 2 of the Joint EFP/AAP Workshop – 2013

The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults
J Slots, L Bragd, M Wikström, G Dahlén – 1986

Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment
J Slots, M Ting – 1999

Antibiotics in periodontal therapy: advantages and disadvantages
J Slots, TE Rams – 1990

The predominant cultivable microflora of advanced periodontitis
J Slots – 1977

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: Prevalence in Patient Groups and Distribution of Biotypes and Serotypes Within Families
JJ Zambon, LA Christersson, J Slots – 1983

Systemic antibiotic therapy in periodontics
AJV Winkelhoff, TE Rams, J Slots – 1996

Microbial differences in 2 clinically distinct types of failures of osseointegrated implants
ES Rosenberg, JP Torosian, J Slots – 1991

The predominant cultivable organisms in juvenile periodontitis
J Slots – 1976

Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline
J Slots, BG Rosling – 1983

Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy
J Slots, P Mashimo, MJ Levine, RJ Genco – 1979

Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease
JJ Zambon, J Slots, RJ Genco – 1983

🏁 Conclusion

Dr. Jørgen Slots’ career stands as a remarkable example of interdisciplinary excellence in dental science. Through his research in periodontal microbiology, leadership in academic institutions, and dedication to global dental education, he has left a lasting legacy. His contributions have not only advanced scientific knowledge but also improved clinical approaches to oral healthcare worldwide. Dr. Slots remains a towering figure whose impact resonates in the fields of periodontology, microbiology, and beyond.

Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Georgia Kaiafa, Medical School, Aristotle University of Thessaloniki,  Greece.

Dr. Georgia Kaiafa is a distinguished hematologist and academician whose career spans clinical excellence, impactful research, and dedicated teaching. A graduate of Aristotle University of Thessaloniki, she earned her MBBS in 1987, Board Certification in Hematology in 1996, and completed her Doctorate in 2005. Her academic roles have progressed from Lecturer to Associate Professor of Hematology and Thromboembolic Diseases, with a longstanding association at AHEPA University Hospital.

Profile

Scopus

 

🎓 Early Academic Pursuits

Georgia Kaiafa began her academic journey in medicine at the prestigious Aristotle University of Thessaloniki, enrolling in the Medical School in 1980. Her foundational training was marked by determination and intellectual rigor, culminating in the completion of her MBBS in 1987. A steadfast commitment to advanced education led her to earn her Board Certification in Haematology by 1996, and later, she successfully defended her Doctorate thesis in 2005. These formative years reflect her deep-rooted passion for understanding hematological science and its clinical applications.

🧬 Professional Endeavors in Hematology

Her professional journey has been nothing short of inspiring, anchored in both clinical excellence and academic growth. Georgia Kaiafa has served in several academic ranks, beginning as a Lecturer in Hematology from 2007 to 2015, advancing to Assistant Professor until 2021, and currently holding the esteemed position of Associate Professor of Hematology and Thromboembolic Diseases. She is affiliated with AHEPA University Hospital’s Hematology Department, a major center of excellence in Greece. Her expertise was further enriched by her tenure as a Visiting Research Associate at King’s College Hospital in London in 2012, where she gained valuable international exposure. Since 2005, she has also played a leadership role as a Coordinator in the Northern Greece Office of the Health Sector, bridging academic medicine and healthcare policy.

🩸 Contributions and Research Focus

Georgia Kaiafa has devoted her scholarly efforts to advancing the understanding of thrombosis, thromboembolic disorders, and hematological malignancies. With her contributions to over 95 peer-reviewed international journal publications and participation as a Principal Investigator in 26 research trials, she has carved out a niche in evidence-based hematological research. Her investigations have deeply influenced protocols and practices in vascular pharmacology, hematologic diagnostics, and the clinical management of thrombotic conditions. She is also a prominent educator, mentoring Ph.D. candidates and contributing to postgraduate programs for both Greek and international students.

🏆 Accolades and Recognition

Her scientific contributions have not gone unnoticed. Georgia Kaiafa has received significant national acclaim, including the 1st Prize Award for Best Paper at the Pan-Hellenic Haematology Conference in 2008 and again at the 1st Conference of Internal Medicine of Northern Greece in 2015. These accolades affirm her research excellence and clinical insight. Her expertise has earned her memberships in elite national and international medical societies, including the Hellenic Stroke Organization and the European Stroke Organization, as well as a respected position in the Excellence of Thrombosis initiative.

🌍 Impact and Influence

Beyond academia and clinical service, Kaiafa has exerted influence on multiple scientific fronts. As a reviewer for prominent journals such as Thrombosis Research, Anemia, Case Reports in Hematology, and the Indian Heart Journal, she ensures high scientific standards in hematologic research worldwide. Her editorial work for both international and Greek journals demonstrates her authority in the field and her dedication to the progression of scientific communication. Her wide-ranging collaborations and committee leadership roles have significantly influenced health education and medical research in Greece and abroad.

📚 Scholarly Engagement and Mentorship

Georgia Kaiafa is not only a prolific researcher but also a passionate mentor and academic contributor. With 23 chapters in medical books, over 130 abstracts in Greek conference proceedings, and nearly 100 abstracts presented in international forums, her voice resonates across the global hematology community. She has mentored and supervised numerous doctoral students, serving on committees for 12 Ph.D. projects and directly supervising five, cultivating the next generation of scientific minds. She has also chaired 22 congress sessions and delivered more than 100 invited talks, emphasizing her respected role as both speaker and thought leader.

🔬 Legacy and Future Contributions

As a seasoned academic and clinical researcher, Georgia Kaiafa continues to shape the future of hematology in Greece and beyond. Her legacy lies in her dual commitment to clinical care and scientific discovery, especially in the realm of thromboembolic diseases and hematologic innovations. Her ongoing involvement in research protocols, editorial responsibilities, and student mentorship assures that her influence will persist. With a solid foundation and a career marked by excellence, her future contributions are likely to further impact hematological sciences and translational medicine globally.

publication

 

  • Title: Monocyte Chemoattractant Protein-1 as a Biomarker in Acute Ischemic Stroke: A Prospective Pilot Study
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Prospective Study of ADAMTS13 and von Willebrand Factor’s Role in the Prediction of Outcomes in Acute Ischemic Stroke
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Antiphospholipid Syndrome: A Comprehensive Clinical Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: The Seasonal Distribution of Immune Thrombotic Thrombocytopenic Purpura is Influenced by Geography: Epidemiologic Findings from a Multi-Center Analysis of 719 Disease Episodes
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Outpatient Management After Hospitalisation for Acute Decompensation of Cirrhosis: A Practical Guide
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Thyroid Disease and Systemic Lupus Erythematosus
    Author(s): [Not specified]
    Year: 2023

 

🏁 Conclusion

Dr. Georgia Kaiafa embodies the values of academic integrity, scientific advancement, and clinical leadership. Her commitment to both national healthcare development and international scientific collaboration sets her apart. With a strong foundation in research, education, and public health, she not only meets but exceeds the criteria for recognition through the Best Researcher Award. Her body of work stands as a testament to sustained excellence and future promise in hematology and related disciplines.

Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Mona Fikry | Cognitive Neuroscience | Best Academic Researcher Award

Assist. Prof. Dr.  Mona Fikry, Faculty of Pharmacy-Cairo University, Egypt.

Dr. Mona Fikry Said, Assistant Professor of Pharmaceutical Chemistry at Cairo University, stands out as a dedicated educator, researcher, and mentor in the field of medicinal chemistry. Her academic journey reflects a blend of deep scientific knowledge and practical teaching expertise. She has supervised numerous postgraduate theses and published extensively in prestigious journals. Her research, particularly in the synthesis and pharmacological evaluation of novel compounds for neurodegenerative diseases, highlights her commitment to addressing real-world health challenges. Beyond her publications, Dr. Said’s influence extends through academic collaboration, curriculum development, and mentorship.

Profile

Google Scholar

🎓 Early Academic Pursuits

Dr. Mona Fikry Said began her academic journey with a strong foundation in pharmaceutical sciences, eventually channeling her passion for medicinal chemistry into advanced academic and research endeavors. Her early commitment to learning laid the groundwork for a career dedicated to both academic excellence and scientific innovation. This formative stage was marked by rigorous study and a growing interest in drug design and discovery, which shaped her professional focus.

🧪 Professional Endeavors

Currently serving as an Assistant Professor of Pharmaceutical Chemistry at the Faculty of Pharmacy, Cairo University, Dr. Said has become a respected educator and mentor in her field. She has been actively involved in teaching a wide array of pharmaceutical chemistry courses and guiding numerous master’s and doctoral students through their theses. Her role extends beyond instruction, as she also participates in academic advising and serves as an external examiner for other institutions.

🔬 Contributions and Research Focus

Dr. Said’s research is deeply rooted in pharmaceutical chemistry, with a particular focus on the development of novel bioactive compounds. Her most recent completed project, “Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies,” exemplifies her multidisciplinary approach to drug discovery. She integrates synthesis, pharmacological testing, and computational modeling to explore new therapeutic avenues, especially for neurodegenerative diseases.

🏅 Accolades and Recognition

While not always publicly documented, Dr. Said’s scientific contributions are widely acknowledged through her publications in high-impact journals such as European Journal of Medicinal Chemistry, Molecular Diversity, Bioorganic Chemistry, and Future Medicinal Chemistry. Her expertise is recognized by her academic peers, and her involvement in national academic programs highlights her standing in the pharmaceutical education community.

🌐 Impact and Influence

Through her publications in SCI and Scopus-indexed journals, Dr. Said has significantly contributed to the body of knowledge in pharmaceutical chemistry. Her work bridges theoretical research and practical applications, influencing both the academic landscape and the early stages of pharmaceutical development. By mentoring postgraduate students and collaborating across institutions, she has helped cultivate a new generation of researchers in Egypt and beyond.

📘 Legacy and Future Contributions

Dr. Said’s lasting impact lies not only in her research but also in her educational leadership. With each class she teaches and each thesis she supervises, she sows the seeds for future advancements in medicinal chemistry. Her continued involvement in clinical academic programs and university examinations ensures that her influence will resonate across institutions for years to come. Looking forward, her research aims to expand into more diverse therapeutic targets, further strengthening Cairo University’s role in pharmaceutical innovation.

🧬 Research Vision in Pharmaceutical Chemistry

With an enduring commitment to discovery, Dr. Mona Fikry Said envisions a research future driven by interdisciplinary collaboration and the integration of cutting-edge techniques. Her dedication to the design and synthesis of multitarget agents reflects a broader mission to combat complex diseases like Alzheimer’s. In doing so, she positions herself at the forefront of modern pharmaceutical chemistry, where innovation and impact go hand in hand.

Publication

  • Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents
    FA Ragab, NMA Gawad, HH Georgey, MF Said
    2013

 

  • Design and synthesis of ibuprofen-quinoline conjugates as potential anti-inflammatory and analgesic drug candidates
    AM Ghanim, AS Girgis, BM Kariuki, N Samir, MF Said, A Abdelnaser, …
    2022

 

  • Pyrazolone derivatives: Synthesis, anti-inflammatory, analgesic, quantitative structure–activity relationship and in vitro studies
    FAF Ragab, NM Abdel-Gawad, HH Georgey, MF Said
    2013

 

  • Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII
    RF George, MF Said, S Bua, CT Supuran
    2020

 

  • Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors
    MF Said, RF George, A Petreni, CT Supuran, NM Mohamed
    2022

 

  • Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors
    HH Hassanein, HH Georgey, MA Fouad, AM El Kerdawy, MF Said
    2017

 

  • New NSAID conjugates as potent and selective COX-2 inhibitors: Synthesis, molecular modeling and biological investigation
    RM Bokhtia, SS Panda, AS Girgis, N Samir, MF Said, A Abdelnaser, …
    2023

 

  • Development of Isatin‐Based Schiff Bases Targeting VEGFR‐2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies
    IA Seliem, SS Panda, AS Girgis, QL Tran, MF Said, MS Bekheit, …
    2022

 

  • Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential
    MF Said, HH Georgey, ER Mohammed
    2021

 

  • Novel Curcumin Mimics: Design, Synthesis, Biological Properties and Computational Studies of Piperidone‐Piperazine Conjugates
    MA Youssef, SS Panda, DR Aboshouk, MF Said, A El Taweel, M GabAllah, …
    2022

 

✅ Conclusion

Through her unwavering dedication to pharmaceutical chemistry, Dr. Said has carved out a meaningful role in academia and research. Her work not only advances scientific understanding but also nurtures future innovators in the field. With a strong foundation in both teaching and research, and a vision for multidisciplinary innovation, she is poised to continue making impactful contributions to drug discovery and pharmaceutical education in the years to come.

Daon Hwang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Daon Hwang | Clinical Neuroscience | Best Researcher Award

Mr. Daon Hwang,  Depatment of Physical Therapy, Korea Natiional University of Transportation,  South Korea.

Daon Hwang is a dedicated physical therapist and Ph.D. candidate at Korea National University of Transportation, with a strong academic and clinical foundation in adult neurological rehabilitation. His research portfolio includes six completed projects and six peer-reviewed publications, focusing on stroke rehabilitation, gait analysis, neurorehabilitation, and assistive device development. With a practical background in clinical therapy and consulting experience in device usability, he effectively bridges the gap between research and real-world application. His active involvement in professional organizations further enriches his contributions to the rehabilitation field.

Profile

Orcid

🎓 Early Academic Pursuits

Daon Hwang began his academic journey with a deep interest in the human body and its recovery mechanisms, leading him to pursue a career in physical therapy. He earned both his Bachelor’s and Master’s degrees in Physical Therapy from Korea National University of Transportation (KNUT). His early academic years were marked by diligence and a curiosity-driven approach to the complexities of neurological rehabilitation. His strong academic performance and growing passion for evidence-based practice set the stage for his current doctoral research.

💼 Professional Endeavors

As a licensed physical therapist, Daon Hwang has accumulated meaningful clinical experience, particularly in the field of adult neurological rehabilitation. His hands-on work with stroke patients has fueled his commitment to integrating practical therapy with innovative research. His current role as a Ph.D. candidate at KNUT allows him to bridge clinical practice with academic exploration, where he also provides consultancy on assistive devices. Daon continues to evolve both as a practitioner and as a scholar in the rehabilitation sciences.

🧠 Contributions and Research Focus

Daon’s primary research focuses include stroke rehabilitation, neurorehabilitation, gait analysis, and the development of assistive technologies. He has successfully completed six research projects, exploring diverse aspects such as proprioceptive training and the usability of rehabilitation devices. His scholarly output includes six peer-reviewed journal publications—two in SCI-indexed journals and four in KCI-indexed journals. These works contribute to enhancing therapeutic protocols and improving patients’ functional outcomes, particularly in post-stroke recovery.

🧪 Research Innovation and Impact

Daon’s innovative contributions are evident in his work with assistive device usability, having collaborated on three industry consulting projects to improve device design and user experience for stroke patients. His research has not only advanced academic knowledge but also offered real-world applicability in clinical settings. His studies often highlight the integration of biomechanical analysis and rehabilitation techniques to create more personalized and effective interventions.

🏅 Accolades and Professional Involvement

While Daon Hwang has not yet published books or acquired patents, his membership in several esteemed professional bodies reflects his dedication to continued learning and contribution to the field. He is an active member of the Korean Academy of Orthopedic Manipulative Physical Therapy, the Korean Physical Therapy Association, and the Korea Proprioceptive Neuromuscular Facilitation Association. Through these affiliations, he stays at the forefront of developments in physical therapy and rehabilitation science.

🌍 Influence and Collaboration

Though he has not formally reported collaborative research projects, Daon’s consulting work and clinical partnerships demonstrate a growing sphere of influence. His findings are increasingly referenced by peers and practitioners, particularly in the areas of gait mechanics and neuro-motor rehabilitation. His dual role in academia and practice ensures his research remains grounded in clinical relevance.

🔮 Legacy and Future Contributions

Looking ahead, Daon Hwang aspires to further integrate technology with neurorehabilitation strategies, aiming to develop more efficient, adaptive tools for stroke survivors. His doctoral work and future post-doctoral goals center on refining rehabilitative methods through data-driven research and interdisciplinary collaboration. With a vision of contributing meaningfully to global rehabilitation science, Daon is poised to leave a lasting legacy of innovation, empathy, and excellence in physical therapy.

Publication

  • Title: Usability Test for an Over-Ground Walking Assistance Robotic Device Based on the Mecanum Wheel
    Authors: Daon Hwang; EunPyeong Choi; Ki Hun Cho
    Year: 2025

 

  • Title: Changes in Balance Ability, Physical Performance and Lower Extremity Proprioception according to the Compression Stockings in University Students
    Authors: Daon Hwang; Hyeong Gyu Kim; Na Young Kang; Eun Seo Park; Hyun Young Yoo; Jun Young Lee; Seo Yeong Jang; Cheol Woo Hwang; Ki Hun Cho
    Year: 2025

 

  • Title: Usability Test for a Cane-Combined Weight Support Feedback Device
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2024

 

  • Title: Usability Test for Motion Tracking Gait Assistive Walker
    Authors: Daon Hwang; Ki Hun Cho
    Year: 2023

 

  • Title: The Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke: A Pilot Study
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

  • Title: Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke
    Authors: Min-Su Song; Soon-Hee Kang
    Year: 2021

 

✅ Conclusion

Driven by a passion for enhancing recovery outcomes in stroke patients, Daon Hwang has positioned himself as a promising scholar and practitioner in the field of physical therapy. His blend of academic rigor, clinical expertise, and innovation in assistive technologies reflects a career marked by meaningful impact and ongoing growth. As he advances toward completing his Ph.D., his work continues to shape the future of neurorehabilitation—promoting evidence-based practices and contributing to patient-centered healthcare innovations.